Skip to main content

Advertisement

SpringerLink
Log in

Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

Background

Propofol, an extensively used intravenous anesthetic agents during cancer resection surgery, has been confirmed to execute anti-tumor effect on multiple cancers, including colorectal cancer (CRC). Although the role of propofol in CRC has been previously reported, its action mechanism remains poorly understood. This study further explored the biological function and underlying mechanism of propofol in CRC cells.

Methods

The cell proliferation, migration and invasion were assessed by methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay, wound healing assay and transwell assay, respectively. The expression levels microRNA-124-3p.1 (miR-124-3p.1) and AKT serine/threonine kinase 3 (AKT3) was analyzed by quantitative real-time polymerase chain reaction. Western blot assay was employed to measure the protein expression of MMP-9, Vimentin and Cyclin D1. The interaction between miR-124-3p.1 and AKT3 was predicted by TargetScan and confirmed by dual-luciferase reporter assay.

Results

Propofol inhibited CRC cell proliferation, migration and invasion. Knockdown of miR-124-3p.1 or AKT3 upregulation reversed the inhibitory effects of propofol on CRC cell proliferation and metastasis. Besides, AKT3 was a direct target of miR-124-3p.1 and its overexpression abated the anti-tumor effect of miR-124-3p.1 on CRC cell proliferation and metastasis.

Conclusion

Propofol inhibited CRC cell proliferation, migration and invasion by upregulating miR-124-3p.1 and downregulating AKT3, providing a new sight for propofol treatment of CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Akcakaya P et al (2011) miR-185 and miR-133b deregulation is associated with overall survival and metastasis in colorectal cancer. Int J Oncol 39(3):11–318

    Google Scholar 

  • Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297

    Article  CAS  Google Scholar 

  • Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215

    Article  CAS  Google Scholar 

  • Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378

    Article  Google Scholar 

  • Chidambaran V, Costandi A, D’Mello A (2015) Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs 29:543–563

    Article  CAS  Google Scholar 

  • Cristiano BE et al (2006) A specific role for AKT3 in the genesis of ovarian cancer through modulation of G2-M phase transition. Cancer Res 66:11718–11725

    Article  CAS  Google Scholar 

  • Fang Y, Liang X, Xu J, Cai X (2018) miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer. Cancer Manage Res 10:6537

    Article  CAS  Google Scholar 

  • Ferrari P et al (2007) Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 121:2065–2072

    Article  CAS  Google Scholar 

  • Grottke A et al (2016) Downregulation of AKT3 increases migration and metastasis in triple negative breast cancer cells by upregulating S100A4. PLoS ONE 11:e0146370

    Article  Google Scholar 

  • Hers I, Vincent EE, Tavaré JM (2011) Akt signalling in health and disease. Cell Signal 23:1515–1527

    Article  CAS  Google Scholar 

  • Huang X, Teng Y, Yang H, Ma J (2016) Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal. Braz J Med Biol Res. https://doi.org/10.1590/1414-431x20165717

    Article  PubMed  PubMed Central  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  Google Scholar 

  • Jiang S, Liu Y, Huang L, Zhang F, Kang R (2018) Effects of propofol on cancer development and chemotherapy: potential mechanisms. Eur J Pharmacol 831:46–51

    Article  CAS  Google Scholar 

  • Liu Z, Zhang J, Hong G, Quan J, Zhang L, Yu M (2016) Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway. Am J Transl Res 8:4120

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ma Y et al (2012) miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut 61:1447–1453

    Article  Google Scholar 

  • Miao Y, Zhang Y, Wan H, Chen L, Wang F (2010) GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomed Pharmacother 64:583–588

    Article  CAS  Google Scholar 

  • Mo X, Cao Q, Liang H, Liu J, Li H, Liu F (2016) MicroRNA-610 suppresses the proliferation of human glioblastoma cells by repressing CCND2 and AKT3. Mol Med Rep 13:1961–1966

    Article  CAS  Google Scholar 

  • Ren YL, Zhang W (2019) Propofol promotes apoptosis of colorectal cancer cells via alleviating the suppression of lncRNA HOXA11-AS on miRNA let-7i. Biochem Cell Biol. https://doi.org/10.1139/bcb-2018-0235

    Article  PubMed  Google Scholar 

  • Shi X-B et al (2013) Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene 32:4130

    Article  CAS  Google Scholar 

  • Siddiqui RA et al (2005) Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells. Breast Cancer Res 7:R645

    Article  CAS  Google Scholar 

  • Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11–30

    Article  Google Scholar 

  • Siegel R, DeSantis C, Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64:104–117

    Article  Google Scholar 

  • Stahl JM et al (2004) Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Res 64:7002–7010

    Article  CAS  Google Scholar 

  • Sun H, Gao D (2018) Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372. BMC Cancer 18:1252

    Article  CAS  Google Scholar 

  • Sun Y, Zhao X, Zhou Y, Hu Y (2012) miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect. Oncol Rep 28:1346–1352

    Article  CAS  Google Scholar 

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108

    Article  Google Scholar 

  • Vasileiou I et al (2009) Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol 605:1–8

    Article  CAS  Google Scholar 

  • Wang YX, Zhu HF, Zhang ZY, Ren F, Hu YH (2018) MiR-384 inhibits the proliferation of colorectal cancer by targeting AKT3. Cancer Cell Int 18:124. https://doi.org/10.1186/s12935-018-0628-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Xia J et al (2012) miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol 227:470–480

    Article  CAS  Google Scholar 

  • Xu K, Tao W, Su Z (2018) Propofol prevents IL-13-induced epithelial–mesenchymal transition in human colorectal cancer cells. Cell Biol Int 42:985–993

    Article  CAS  Google Scholar 

  • Ye Z, Jingzhong L, Yangbo L, Lei C, Jiandong Y (2014) Propofol inhibits proliferation and invasion of osteosarcoma cells by regulation of microRNA-143 expression. Oncol Res Featur Preclin Clin Cancer Ther 21:201–207

    Google Scholar 

  • Yue D, Liu H, Huang Y (2009) Survey of computational algorithms for microRNA target prediction. Curr Genomics 10:478–492

    Article  CAS  Google Scholar 

  • Zhang J et al (2013a) MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS ONE 8:e70300

    Article  CAS  Google Scholar 

  • Zhang J, Zhang D, Wu G-Q, Feng Z-Y, Zhu S-M (2013b) Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. Hepatobiliary Pancreatic Dis Int 12:305–309

    Article  CAS  Google Scholar 

  • Zhang H, Wang Q, Zhao Q, Di W (2013c) MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. J Ovarian Res 6:84

    Article  Google Scholar 

  • Zhang D et al (2015) Propofol promotes cell apoptosis via inhibiting HOTAIR mediated mTOR pathway in cervical cancer. Biochem Biophys Res Commun 468:561–567

    Article  CAS  Google Scholar 

  • Zhang W, Wang Y, Zhu Z, Zheng Y, Song B (2018) Propofol inhibits proliferation, migration and invasion of gastric cancer cells by up-regulating microRNA-195. Int J Biol Macromol 120:975–984

    Article  CAS  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Anesthesiology, The First People’s Hospital of Yunnan Province, Jin Bi Road, Xishan District, Kunming, 650000, Yunnan, China

    Yujin Li & Gaopeng Xiao

  2. Department of Anesthesiology, Yongping County People’s Hospital, Dali, 672600, Yunnan, China

    Wangjun Dong

  3. Department of Anesthesiology, The Second People’s Hospital of Kunming, Kunming, 650000, Yunnan, China

    Hao Yang

Authors
  1. Yujin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wangjun Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hao Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gaopeng Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gaopeng Xiao.

Ethics declarations

Conflict of interest

The authors declare that they do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Y., Dong, W., Yang, H. et al. Propofol suppresses proliferation and metastasis of colorectal cancer cells by regulating miR-124-3p.1/AKT3. Biotechnol Lett 42, 493–504 (2020). https://doi.org/10.1007/s10529-019-02787-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-019-02787-y

Keywords

Search

Navigation